The test is based on a set of reagents produced in Russia, which can significantly reduce their cost compared to analogues and ensure their widespread use in clinical practice. It allows the analysis of” complex " samples with a small amount of DNA (from 10 ng), including fragmented DNA from archival biomaterial.